Simtra US LLC
Simtra US LLC is a drug establishment in Bloomington, United States, registered with the US FDA under FEI 1000115571. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging, Relabelling, Sterilisation. 1 EU/UK GMP certificate is matched to this site, 1 inspected within the last three years. FDA has published 12 inspection outcomes for this FEI; the most recent, ended 24 Sept 2024, was classified voluntary action indicated (VAI).
Sources: FDA Drug Establishments Current Registration Site (checked 16 Nov 2026); FDA Data Dashboard (inspections); EudraGMDP; MHRA GMDP. Methodology
Cite as: PharmaTek, “Simtra US LLC: FDA registration, inspection and GMP record (FEI 1000115571)”, record as of 16 Nov 2026, pharmatek.co.uk/manufacturing-sites/simtra-us-llc-bloomington-1000115571
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (1)
| Document | Authority | Inspection | Source |
|---|---|---|---|
NL/H 26/2059734 GMP certificate | Competent authority of Netherlands | 14 Aug 2026 within 3-year review window | EudraGMDP |
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
FDA inspection outcomes (12)
| Inspection ended | Outcome | Programme area | Citations posted |
|---|---|---|---|
| 24 Sept 2024 | VAI · Voluntary action indicated | Drug Quality Assurance | No |
| 17 Feb 2023 | NAI · No action indicated | Drug Quality Assurance | No |
| 17 Jul 2017 | VAI · Voluntary action indicated | Drug Quality Assurance | Yes |
| 24 Oct 2014 | VAI · Voluntary action indicated | Drug Quality Assurance | No |
| 2 May 2014 | NAI · No action indicated | Drug Quality Assurance | No |
| 10 May 2013 | VAI · Voluntary action indicated | Drug Quality Assurance | Yes |
| 12 Mar 2013 | VAI · Voluntary action indicated | Drug Quality Assurance | Yes |
| 27 Sept 2012 | VAI · Voluntary action indicated | Drug Quality Assurance | No |
| 16 Aug 2011 | NAI · No action indicated | Drug Quality Assurance | No |
| 25 Mar 2011 | VAI · Voluntary action indicated | Drug Quality Assurance | Yes |
| 23 Sept 2010 | VAI · Voluntary action indicated | Drug Quality Assurance | No |
| 30 Oct 2009 | NAI · No action indicated | Drug Quality Assurance | No |
FDA Data Dashboard, joined on the FEI. NAI: no objectionable conditions found. VAI: objectionable conditions found, but not serious enough for regulatory action. OAI: regulatory or administrative action recommended. A classification describes one inspection on one date; FDA publishes it only once final and does not publish every inspection. FDA firm profile
Form 483 observations (9)
Inspection ended 17 Jul 2017: 1 observation
- 21 CFR 211.113(b) Validation lacking for sterile drug products
Inspection ended 10 May 2013: 4 observations
- 21 CFR 211.22(d) Procedures not in writing, fully followed
- 21 CFR 211.80(a) Procedures To Be in Writing
- 21 CFR 211.100(b) SOPs not followed / documented
- 21 CFR 211.84(d)(3) Certificates of Testing (Containers, Closures)
Inspection ended 12 Mar 2013: 2 observations
- 21 CFR 211.113(b) Procedures for sterile drug products
- 21 CFR 211.192 Extent of discrepancy, failure investigations
Inspection ended 25 Mar 2011: 2 observations
- 21 CFR 211.192 Extent of discrepancy, failure investigations
- 21 CFR 211.22(d) Procedures not in writing, fully followed
FDA Data Dashboard (inspection citations), joined on the FEI. Each line is the regulation cited and FDA's short description, not the full observation text. A Form 483 lists an investigator's observations at the close of an inspection; it is not a final agency determination, and FDA does not publish citations for every inspection.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- The full text of a Form 483 or warning letter: FDA's dashboard gives the regulation cited and a short description only.
Other sites registered by the same company
Is this SIMTRA US LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.